The Breast
Volume 19, Issue 3 , Pages 238-242 , June 2010

Visual analogue scale for assessing breast nodularity in non-discrete lumpy breasts: The Lucknow – Cardiff breast nodularity scale

  • Sandeep Kumar

      Affiliations

    • Department of Surgery, King George's Medical University, Lucknow 226 003, UP, India
    • Corresponding Author InformationCorresponding author. Tel.: +91 522 225 7388 (office), 232 2577 (home), 9335 240 880 (mobile); fax: +91 522 225 7674.
    • ,
  • Ruchi Rai

      Affiliations

    • Department of Surgery, King George's Medical University, Lucknow 226 003, UP, India
    • ,
  • Vinita Das

      Affiliations

    • Department of Obstetrics and Gynecology, KG Medical University, Lucknow, India
    • ,
  • Surender Kumar

      Affiliations

    • Department of Surgery, King George's Medical University, Lucknow 226 003, UP, India
    • ,
  • Varsha Dwivedi

      Affiliations

    • Department of Surgery, King George's Medical University, Lucknow 226 003, UP, India
    • ,
  • G.G. Agrawal

      Affiliations

    • Department of Statistics, Lucknow University, Lucknow, India

Received 27 July 2009 ,Revised 6 October 2009 ,Accepted 4 February 2010.

References 

  1. Nichols S, Waters WE, Wheeler MJ. Management of female breast disease by Southampton general practitioners. Br J Surg. 1980;281:1450–1453
  2. Roberts MM, Elton RA, Robinson SE, French K. Consultations for breast disease in general practice and hospital referral patterns. Br J Surg. 1987;74:1020–1022
  3. Shukla HS, Kumar S. Benign breast disorders in non-western population part II benign breast disorders in India. World J Surg. 1989;13:746–749
  4. Rangabashyam N, Ganaprakasam D, Krishnaraj DB, Manohar V, Vijayalakshmi SR. Spectrum of benign lesions in Madras. J Roy Coll Surg Edin. 1983;28:369
  5. Hughes LE. Benign breast disorders–introduction. fibrocystic disease? nondisease? or ANDI?. World J Surg. 1989;13:667–668
  6. Smoller SW. Biostatistics and epidemiology: a primer for health professionals. In: second ed. p. 33–4.
  7. Mansel RE, Preece PE, Huges LE. A double blind trial of the prolactin inhibitor bromocriptine in painful benign breast disease. Br J Surg. 1978;65:724–727
  8. Parlatti E, Polinari U, Salvi G. Bromocriptine for the treatment of benign breast disease. A double blind clinical trial versus placebo. Acta Obstet Gynecol Scand. 1987;66:483–488
  9. Ernster VL, Goodson WH, Hunt TK, Petrakis NL, Sickles EA, Miike R. Vitamin E and benign breast “disease”: a double blind, randomized clinical trial. Surgery. 1985;97:490–494
  10. Ernster VL, Mason L, Goodson WH. Effects of caffeine free diet on benign breast disease: a randomized trial. Surgery. 1982;91:263–267
  11. Haagensen CD. Diseases of the breast. Revised reprint 2nd ed.. Philadelphia, Pa: WB Saunders Co; 1971;
  12. Goodson WH, Moore DH. Overall clinical breast examination as a factor in delayed diagnosis of breast cancer. Arch Surg. 2002;137:1152–1156
  13. Goodson WH, Moore DH. Causes of physician delay in the diagnosis of breast cancer. Arch Intern Med. 2002;162:1343–1148
  14. Wisbey JR, Kumar S, Mansel RE, Preece PE, Pye JK, Hughes LE. Natural history of breast pain. Lancet. 1983;ii:672–674
  15. Goodson WH, Miller TR, Sickle EA, Upton RA. Lack of correlation of clinical breast examination with high risk histopathology. Am J Med. 1990;89:752–756
  16. Foote FW, Stewart FW. Comparative studies of cancerous versus non-cancerous breasts. Ann Surg. 1945;6:121
  17. Murray CJL, Lopez AD. The global burden of disease. Pub: the Harvard school of public health. vol. 1. WHO & World Bank, Harvard University Press; 1996;p. 1–5

PII: S0960-9776(10)00046-9

doi: 10.1016/j.breast.2010.02.002

The Breast
Volume 19, Issue 3 , Pages 238-242 , June 2010

Article Tools

* Image Usage & Resolution